Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 2101 AL 2115

Clonal CD8 T cells in the leptomeninges are locally controlled and influence microglia in human neurodegeneration

Hobson R, Levy SHS, Flaherty D, Xiao H, Ciener B, Reddy H, Singal C, Teich AF, Shneider NA, Bradshaw EM, Elyaman W.

bioRxiv [Preprint]. 2023 Jul 14:2023.07.13.548931. doi: 10.1101/2023.07.13.548931.

Comparison of gene expression in living and postmortem human brain

Collado-Torres L, Klei L, Liu C, Kleinman JE, Hyde TM, Geschwind DH, Gandal MJ, Devlin B, Weinberger DR.

medRxiv [Preprint]. 2023 Nov 9:2023.11.08.23298172. doi: 10.1101/2023.11.08.23298172.

Oxidative Stress and Neuroinflammation in Parkinson's Disease: The Role of Dopamine Oxidation Products

Chakrabarti S, Bisaglia M.

Antioxidants (Basel). 2023 Apr 18;12(4):955. doi: 10.3390/antiox12040955.

Insights into Advanced Neurological Dysfunction Mechanisms Following DBS Surgery in Parkinson's Patients: Neuroinflammation and Pyroptosis

Meng H, Wei JH, Yu PZ, Ren JX, Tang MY, Sun JY, Yan XY, Su J.

Curr Issues Mol Biol. 2023 May 20;45(5):4480-4494. doi: 10.3390/cimb45050284.

The Enigmatic CA2: Exploring the Understudied Region of the Hippocampus and Its Involvement in Parkinson's Disease

Zhao F, Behnisch T.

Biomedicines. 2023 Jul 14;11(7):1996. doi: 10.3390/biomedicines11071996.

Autophagy in Parkinson's Disease

Nechushtai L, Frenkel D, Pinkas-Kramarski R.

Biomolecules. 2023 Sep 22;13(10):1435. doi: 10.3390/biom13101435.

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson's disease

Jenner P, Falup-Pecurariu C, Leta V, Verin M, Auffret M, Bhidayasiri R, Weiss D, Borovečki F, Jost WH.

J Neural Transm (Vienna). 2023 Nov;130(11):1337-1347. doi: 10.1007/s00702-023-02655-0. Epub 2023 May 20.

Levodopa-Induced Dyskinesias in Parkinson's Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions

di Biase L, Pecoraro PM, Carbone SP, Caminiti ML, Di Lazzaro V.

J Clin Med. 2023 Jun 30;12(13):4427. doi: 10.3390/jcm12134427.

Updates on brain regions and neuronal circuits of movement disorders in Parkinson's disease

Wang J, Wang X, Li H, Shi L, Song N, Xie J.

Ageing Res Rev. 2023 Dec;92:102097. doi: 10.1016/j.arr.2023.102097. Epub 2023 Oct 28.

Therapeutic implications of crocin in Parkinson's disease: A review of preclinical research

Goyal A, Verma A, Agrawal A, Dubey N, Kumar A, Behl T.

Chem Biol Drug Des. 2023 Jun;101(6):1229-1240. doi: 10.1111/cbdd.14210. Epub 2023 Feb 19.

Is Glial Dysfunction the Key Pathogenesis of LRRK2-Linked Parkinson's Disease?

Iseki T, Imai Y, Hattori N.

Biomolecules. 2023 Jan 15;13(1):178. doi: 10.3390/biom13010178.

The Role of Exercise in Maintaining Mitochondrial Proteostasis in Parkinson's Disease

Li J, Xu Y, Liu T, Xu Y, Zhao X, Wei J.

Int J Mol Sci. 2023 Apr 28;24(9):7994. doi: 10.3390/ijms24097994.

Selective dopaminergic vulnerability in Parkinson's disease: new insights into the role of DAT

Harraz MM.

Front Neurosci. 2023 Aug 24;17:1219441. doi: 10.3389/fnins.2023.1219441. eCollection 2023.

2.2 Continous dopaminergic stimulation: concept and evidence

Metman LV, Mouradian MM.

In: Odin P, Chaudhuri KR, Aquilonious SM, Mundt-Petersen U, editors. Where are We? Continuous Dopaminergic Stimulation for Parkinson's Disease [Internet]. Berkshire (UK): Empowering Strategic Performance Ltd; 2023 Jan 1.

Mechanism of Mesenchymal Stem Cells as a Multitarget Disease- Modifying Therapy for Parkinson's Disease

Unnisa A, Dua K, Kamal MA.

Curr Neuropharmacol. 2023;21(4):988-1000. doi: 10.2174/1570159X20666220327212414.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias